Carregant...

When and why women might suspend PrEP use according to perceived seasons of risk: implications for PrEP-specific risk-reduction counselling

Oral pre-exposure prophylaxis (PrEP) using the antiretroviral drug emtricitabine/tenofovir disoproxil fumarate (Truvada) has been shown to dramatically reduce the risk of HIV acquisition for women at higher risk of infection if taken daily. Understanding when and why women would intentionally stop u...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cult Health Sex
Autors principals: Namey, Emily, Agot, Kawango, Ahmed, Khatija, Odhiambo, Jacob, Skhosana, Joseph, Guest, Greg, Corneli, Amy
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5049692/
https://ncbi.nlm.nih.gov/pubmed/27093238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13691058.2016.1164899
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!